Private Capital
Private Capital is EQT’s largest business segment.
Key metrics
Investing from early-stage VC through to longer-hold, mature buyouts across the world.
Comprising seven business lines: EQT Private Equity, EQT Private Capital Asia, EQT Future, EQT Ventures, EQT Life Sciences, EQT Growth and EQT Healthcare Growth. The Private Capital segment has grown rapidly and achieved strong returns throughout its history.
Business lines
EQT Private Equity
Investment range
The EQT Private Equity Advisory Team has vast investment expertise, industry and sector knowledge, and extensive networks in the local business communities and societies in which it operates. With a strong sector-based approach and by maintaining a local-with-locals presence, the team is uniquely positioned to analyze companies and the markets in which they operate, and to develop proprietary investment opportunities.
EQT Private Capital Asia
Investment range
EQT Private Capital Asia has been transforming Asian companies through its pan-Asian investment platform for over 25 years. With a top-down thematic origination model and value creation centered around active ownership and transformation, the team is uniquely positioned to identify and source compelling investment opportunities across the entire region.
EQT Ventures
Investment range
The EQT Ventures Advisory Team aims to support great entrepreneurs throughout different stages of growth, providing access to capital and in-depth specialist experience. The EQT Ventures funds employ a multi-stage strategy to make equity investments, typically ranging from late seed rounds all the way to growth rounds. This means the EQT Ventures’ support window is wider than a typical single-phase fund.
EQT Future
Investment range
EQT Future's innovative approach enables EQT to hold companies for longer, leveraging EQT’s proven active ownership approach and a tailored impact management and measurement toolbox to drive attractive downside-protected returns.
The Fund is Article 9 classified and has innovated around ways to align sustainability with financial returns, linking carried interest to sustainability targets.
The Fund seeks to generate net positive impact in portfolio companies through two pathways: 1) identifying and incentivizing a pivot from the existing market offering at the time of investment towards products and services with a measurable positive impact; and/or 2) scaling existing impactful products and services for greater reach and depth of impact.
EQT Future sets portfolio-wide sustainability targets for its investments to transform how businesses are operated. The targets are supplemented with tailored impact KPIs for each business, designed to accelerate the positive impact of the company’s products or services.
The EQT Impact Toolbox
EQT Future screens for, monitors, and manages for impact outcomes throughout the investment process by using its Impact Toolbox. This includes rigorous management and measurement, such as:
- negative and positive screening
- assessment templates inspired by industry gold-standards (such as the Operating Principles for Impact Management and the Impact Management Project’s 5 Dimensions of Impact)
- bespoke impact acceleration plans to support base and upside impact cases
- support from EQT’s Impact Advisors and the Mission Board
In addition, EQT Future tracks asset-level impact KPIs, aligned with the business impact case, as well as three sustainability performance KPIs across the portfolio:
- GHG emissions reductions, in line with the Science Based Targets
- Improved employee well-being through industry top-quartile employee Net Promoter Score
- Increased gender diversity, where progress is tracked towards a 50 percent split within the top 20 percent of earners in the company
EQT Life Sciences
Investment range
EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. With a track record going back 30 years, EQT Life Sciences has raised more than €3 billion, and invested in over 150 private companies. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine, science, and industry, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek.
EQT Growth
Investment range
EQT Growth invests in companies within four primary tech sub-sectors: enterprise, con/prosumer, health, and climate. It partners with companies supported by long-term macro trends, deeply researching each sub-sector so it can invest with complete conviction in the companies that are truly primed for enduring success.
With a team based in five countries across Europe, and support from EQT Group’s global network, EQT Growth’s local presence ensures direct access to many of the continent’s most-established tech hubs.